Skip to main content
Premium Trial:

Request an Annual Quote

Prostate Cancer Foundation Gets $7M Donation for Dream Team Project

NEW YORK (GenomeWeb News) – The Prostate Cancer Foundation plans to use a $7 million donation from New York billionaire Stewart Rahr to fund a multi-partner research project that will use genomic medicine and other approaches to discover new prostate cancer treatments.

PCF said today that $5 million of the gift will fund a partnership with Stand Up to Cancer, called the Dream Team, that involves investigators at multiple institutes. The researchers will develop protocols, based on genomics, informatics, clinical genetics, and pathology to enable physicians to provide targeted treatments within five weeks of a positive biopsy.

The Dream Team project is led by Arul Chinnaiyan, director of the University of Michigan Center for Translational Pathology, and Charles Sawyers, chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center.

Other Dream Team partners include researchers at the Broad Institute, Dana Farber Cancer Institute, Fred Hutchinson Cancer Research Center, the Institute of Cancer Research/The Royal Marsden Hospital in London, and Weill Cornell Medical College.

PCF will use the remaining $2 million from the donation to fund its other grant programs, including the Creativity, Challenge, and Young Investigator Awards.

In September PCF awarded $3 million through its Challenge Awards program for research efforts using genetics and genomics approaches, including genome sequencing and gene expression-based studies aimed at developing personalized cancer treatments.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.